Sonrgy is a preclinical stage biotechnology startup based out of San Diego, CA.  Founded in 2012, Sonrgy’s primary goal is the development of its proprietary drug delivery platform SonRx. Initially conceived by researchers at UC San Diego Moores Cancer Center, Sonrgy’s core technology is a revolutionary form of chemotherapy which aims to improve both quality of life and survival for millions of cancer patients.

The system combines a breakthrough nanotechnology with a focused beam of ultrasound to directly target tumors for drug release. This allows chemotherapy agents to attack cancer sites and minimize exposure with the rest of the body’s tissues, in order to significantly reduce side effects and improve efficacy of treatment.

If you would like to learn more, please contact us.